Ventricular Assist Devices: Challenges of the One-device Era.
HeartMate 3
HeartWare
left ventricular assist device
mechanical circulatory support
paediatric mechanical circulatory support
Journal
Cardiac failure review
ISSN: 2057-7540
Titre abrégé: Card Fail Rev
Pays: England
ID NLM: 101696210
Informations de publication
Date de publication:
Jan 2022
Jan 2022
Historique:
received:
05
01
2022
accepted:
22
04
2022
entrez:
16
1
2023
pubmed:
17
1
2023
medline:
17
1
2023
Statut:
epublish
Résumé
Heart failure (HF) is linked to to high mortality rates and recurrent hospitalisations despite medical and device-based achievements. The use of left ventricular assist devices (LVADs) has improved survival among patients with advanced HF. Significant progress has been achieved with the new generation of continuous-flow devices, particularly with the fully magnetically levitated HeartMate 3. In June 2021, Medtronic announced the abrupt withdrawal of the HeartWare device from the market. This decision has introduced a new era in which the field of mechanical support for advanced HF patients is dominated by a single device - the HeartMate 3. The direct clinical and economic consequences of this change will necessitate new surgical considerations. Because of the expected need for HeartWare device replacement in small patients, new surgical techniques and device adaptation will be needed. The new single-device era will hopefully encourage scientists and engineers to create innovations in the advanced HF arena. Special considerations should be taken during the COVID-19 pandemic when treating patients with LVADs.
Identifiants
pubmed: 36644648
doi: 10.15420/cfr.2022.01
pmc: PMC9820067
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
e33Informations de copyright
Copyright © 2022, Radcliffe Cardiology.
Déclaration de conflit d'intérêts
Disclosure: The authors have no conflicts of interest to declare.
Références
ESC Heart Fail. 2021 Dec;8(6):4409-4424
pubmed: 34523254
Ann Thorac Surg. 2020 Mar;109(3):649-660
pubmed: 32115073
Circ Heart Fail. 2021 Apr;14(4):e007957
pubmed: 33813838
Ann Thorac Surg. 2020 Dec;110(6):1819-1831
pubmed: 33039359
JACC Heart Fail. 2018 Sep;6(9):792-802
pubmed: 30007559
J Thorac Cardiovasc Surg. 2009 Jan;137(1):208-15
pubmed: 19154927
ESC Heart Fail. 2021 Dec;8(6):4425-4443
pubmed: 34585525
Eur J Cardiothorac Surg. 2017 May 1;51(5):887-892
pubmed: 28329060
J Heart Lung Transplant. 2020 Jun;39(6):573-579
pubmed: 32111350
Heart. 2010 Jan;96(1):63-71
pubmed: 19617213
ESC Heart Fail. 2021 Dec;8(6):4394-4408
pubmed: 34519177
J Heart Lung Transplant. 2018 May;37(5):579-586
pubmed: 29655662
Ann Cardiothorac Surg. 2018 Jan;7(1):3-11
pubmed: 29492379
Eur J Heart Fail. 2020 Jun;22(6):937-940
pubmed: 32437041
N Engl J Med. 2019 Apr 25;380(17):1618-1627
pubmed: 30883052
Ann Thorac Surg. 2022 Apr;113(4):1172-1182
pubmed: 34087236
ASAIO J. 2021 Sep 1;67(9):1036-1043
pubmed: 33470634
Eur J Cardiothorac Surg. 2020 Jun 1;57(6):1038-1050
pubmed: 32364221
Eur J Heart Fail. 2021 Oct;23(10):1597-1609
pubmed: 34409711
Curr Opin Cardiol. 2020 Mar;35(2):162-169
pubmed: 31834033
Eur Heart J. 2021 Sep 21;42(36):3599-3726
pubmed: 34447992
Circulation. 2013 Apr 23;127(16):1702-11
pubmed: 23538380
Eur J Heart Fail. 2020 Jun;22(6):933-936
pubmed: 32391963
J Heart Lung Transplant. 2017 Apr;36(4):480-481
pubmed: 28089426
Eur J Heart Fail. 2021 Sep;23(9):1428-1431
pubmed: 34296495
Eur J Cardiothorac Surg. 2021 Sep 11;60(3):579-587
pubmed: 33871594
Medicina (Kaunas). 2022 Jan 13;58(1):
pubmed: 35056424
JACC Heart Fail. 2020 Aug;8(8):681-691
pubmed: 32493638
Eur J Heart Fail. 2021 Nov;23(11):1806-1818
pubmed: 34612556
J Card Fail. 2021 Nov;27(11):1291-1294
pubmed: 34139365
Eur J Heart Fail. 2021 Jul;23(7):1226-1237
pubmed: 34142415
ASAIO J. 2021 Aug 1;67(8):825-826
pubmed: 34339397
J Heart Lung Transplant. 2019 Apr;38(4):339-343
pubmed: 30945635